These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28714414)

  • 1. Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies.
    Du X; Zhang J; Wang J; Lin X; Ding F
    Curr Pharm Des; 2018 Feb; 23(39):5997-6010. PubMed ID: 28714414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-based Therapeutic Strategy in Lung Cancer.
    Li G; Fang J; Wang Y; Wang H; Sun CC
    Curr Pharm Des; 2018 Feb; 23(39):6011-6018. PubMed ID: 28745212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-based Therapeutics for Lung Cancer.
    Wu M; Wang G; Tian W; Deng Y; Xu Y
    Curr Pharm Des; 2018 Feb; 23(39):5989-5996. PubMed ID: 28714413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer.
    Zhong S; Golpon H; Zardo P; Borlak J
    Transl Res; 2021 Apr; 230():164-196. PubMed ID: 33253979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA and Lung Cancer.
    Del Vescovo V; Denti MA
    Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as biomarkers and therapeutic drugs in human cancer.
    Osaki M; Takeshita F; Ochiya T
    Biomarkers; 2008 Nov; 13(7):658-70. PubMed ID: 19096960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implication of microrna for lung cancer.
    Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer.
    Tang S; Li S; Liu T; He Y; Hu H; Zhu Y; Tang S; Zhou H
    Cancer Lett; 2021 Apr; 502():71-83. PubMed ID: 33453304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically Correlated MicroRNAs in the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Jiang M; Li X; Quan X; Li X; Zhou B
    Biomed Res Int; 2018; 2018():5930951. PubMed ID: 30050938
    [No Abstract]   [Full Text] [Related]  

  • 11. miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.
    Florczuk M; Szpechcinski A; Chorostowska-Wynimko J
    Target Oncol; 2017 Apr; 12(2):179-200. PubMed ID: 28243959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
    Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
    Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.
    Peng W; Wang J; Shan B; Peng Z; Dong Y; Shi W; He D; Cheng Y; Zhao W; Zhang C; Li B; Duan C
    Cell Physiol Biochem; 2018; 49(2):816-827. PubMed ID: 30165346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue and Blood Biomarkers in Lung Cancer: A Review.
    Duffy MJ; O'Byrne K
    Adv Clin Chem; 2018; 86():1-21. PubMed ID: 30144837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature.
    Gyoba J; Shan S; Roa W; Bédard EL
    Int J Mol Sci; 2016 Apr; 17(4):494. PubMed ID: 27043555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
    Hu S; Yuan Y; Song Z; Yan D; Kong X
    Cell Physiol Biochem; 2018; 51(6):2509-2522. PubMed ID: 30557872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions.
    Leonetti A; Assaraf YG; Veltsista PD; El Hassouni B; Tiseo M; Giovannetti E
    Drug Resist Updat; 2019 Jan; 42():1-11. PubMed ID: 30544036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of miR-15a-5p and CNKSR3 as Novel Prognostic Biomarkers in Non-Small Cell Lung Cancer.
    Ergun S; Güney S; Temiz E; Petrovic N; Gunes S
    Anticancer Agents Med Chem; 2018; 18(12):1695-1701. PubMed ID: 30019650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-associated carcinogenesis in lung carcinoma.
    Pratap P; Raza ST; Abbas S; Mahdi F
    J Cancer Res Ther; 2018; 14(2):249-254. PubMed ID: 29516903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.